Fig. 1From: Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myelomaThe schematic diagram of the structure of an antibody-drug conjugate. Antigens for the monoclonal antibody (mAb), linker types, and payloads that are in clinical development were listedBack to article page